245 results on '"Jacoby, Edgar"'
Search Results
2. Structural and mechanistic insights into the inhibition of respiratory syncytial virus polymerase by a non-nucleoside inhibitor
3. Structure–Activity Relationship of Oxacyclo- and Triazolo-Containing Respiratory Syncytial Virus Polymerase Inhibitors.
4. Discovery of gem-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase Inhibitors.
5. Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML.
6. Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections.
7. Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH Inhibitors
8. The Future of Computational Chemogenomics
9. Accessing the Open PHACTS Discovery Platform with Workflow Tools
10. Extending kinome coverage by analysis of kinase inhibitor broad profiling data
11. From Oxetane to Thietane: Extending the Antiviral Spectrum of 2′-Spirocyclic Uridines by Substituting Oxygen with Sulfur
12. Scientific competency questions as the basis for semantically enriched open pharmacological space development
13. Theoretical and Experimental Relationships between Percent Inhibition and IC50 Data Observed in High-Throughput Screening
14. Divide and Conquer. Pocket-Opening Mixed-Solvent Simulations in the Perspective of Docking Virtual Screening Applications for Drug Discovery
15. The role of computational methods in the identification of bioactive compounds
16. Fuzzy Control in der Diabetestherapie
17. Elements for the Development of Strategies for Compound Library Enhancement
18. N‑Heterocyclic 3‑Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia.
19. Reaction-DrivenDe NovoDesign: a Keystone for Automated Design of Target Family-Oriented Libraries
20. A carboxylic acid isostere screen of the DHODH inhibitor Brequinar
21. Evaluation of the utility of homology models in high throughput docking
22. The Role of Data Mining in the Identification of Bioactive Compounds via High-Throughput Screening
23. Molecular Lipophilicity in Protein Modeling and Drug Design
24. A chemoinformatics analysis of hit lists obtained from high-throughput affinity-selection screening
25. Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction
26. Recent trends and observations in the design of high-quality screening collections
27. FEP+ calculations predict a stereochemical SAR switch for first-in-class indoline NIK inhibitors for multiple myeloma
28. Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro
29. Chemogenomics
30. Annotating and mining the ligand-target chemogenomics knowledge space
31. Fuzzy Control in der Diabetestherapie
32. Protocols for the Design of Kinase-focused Compound Libraries
33. Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode
34. Abstract 4199: Inhibition of NF-kB inducing kinase (NIK) selectively abrogates NIK and TRAF3 mutant multiple myeloma tumor growth
35. Correction to Structural Investigation of B-Raf Paradox Breaker and Inducer Inhibitors
36. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling
37. Protocols for the Design of Kinase‐focused Compound Libraries.
38. Limited Proteolysis Combined with Stable Isotope Labeling Reveals Conformational Changes in Protein (Pseudo)kinases upon Binding Small Molecules
39. PepShell: Visualization of Conformational Proteomics Data
40. Structural Investigation of B-Raf Paradox Breaker and Inducer Inhibitors
41. The Application of the Open Pharmacological Concepts Triple Store (Open PHACTS) to Support Drug Discovery Research
42. Abstract 1797: Discovery of NVP-CGM097, a highly potent and optimized small molecule inhibitor of Mdm2 under evaluation in a Phase I clinical trial
43. Abstract DDT01-01: Discovery of CGM097 as a novel Mdm2 inhibitor
44. The GPCR— 7TM Receptor Target Family
45. A Novel Class of Oral Direct Renin Inhibitors: Highly Potent 3,5-Disubstituted Piperidines Bearing a Tricyclic P3–P1 Pharmacophore
46. The Discovery of Novel Potent trans-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches
47. Probing the Bioactivity-Relevant Chemical Space of Robust Reactions and Common Molecular Building Blocks
48. A Collection of Robust Organic Synthesis Reactions for In Silico Molecule Design
49. Computational chemogenomics
50. ChemInform Abstract: Access to New Cytotoxic Bisindole Alkaloids by a Modified Borch Reductive Amination Process.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.